ConductScience.org, home

Gene · 7369

Papers3,273

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

101 to 120 of 3,273

Download this page as JSON
TitleJournalYearPMIDFound bySource
Genetic Characterization of Lithuanian Patients With Cystic Kidney.Clin Genet202640760778PubTator, text miningPubMed
Acute Kidney Injury at the Onset of Type 1 Diabetes Mellitus: A Balance between Kidney Stress and Nephron Mass.Horm Res Paediatr202640544822PubTator, text miningPubMed
Initial Suspicion of Autosomal Dominant Polycystic Kidney Disease Resulted in a Diagnosis of Autosomal Dominant Tubulointerstitial Kidney Disease Caused by a UMOD Mutation.Intern Med202640533238PubTator, text miningPubMed
Blood Biomarkers for Large Vessel Occlusions: A Systematic Review.Stroke Vasc Interv Neurol202541608703PubTator, text miningPubMed
A Narrative Review of the Genetic Architecture of Systemic Hypertension: From Candidate Genes to Biobank-Scale Genome-Wide Association Studies and Sequencing, With Translational Pathways to Precision Care.
Cureus202541573461PubTator, text miningPubMed
Abstracts of the Annual Meeting of the Iuliu HaţieganuUniversity of Medicine and Pharmacy: 8th - 13th December 2025, Cluj-Napoca.Med Pharm Rep202541496885PubTator, text miningPubMed
Case Report: UMOD gene mutation and phenotypic overlap with REN in autosomal dominant tubulointerstitial kidney disease.Front Genet202541480152PubTator, text miningPubMed
The diagnostic value of uromodulin protein measurement in autosomal dominant tubulointerstitial kidney disease due to uromodulin mutation (ADTKD-UMOD): serum or urine?BMC Nephrol202541462127PubTator, text miningPubMed
Tubular Biomarkers and Retinal Microvasculature: Illuminating Early Cardiovascular-Kidney-Metabolic Pathways Beyond the Glomerulus.Kidney360202541411113PubTator, text miningPubMed
Bridging conventional clinical tests and advanced biomarkers for the early diagnosis of kidney disease progression.Pak J Med Sci202541394384PubTator, text miningPubMed
Kidney injury risk in congenital solitary functioning kidney: the role of nephron mass assessed by serum uromodulin and the rs4293393 T > C polymorphism.BMC Res Notes202541390447PubTator, text miningPubMed
Childhood obesity and DNA methylation in an epigenome-wide association study: findings from the Hokkaido Birth Cohort.Clin Epigenetics202541327469PubTator, text miningPubMed
Half-Space Proximal Networks (HSPNs): A Proxy for Multi-Query Similarity Searching Models Predicting Tumor-Homing Peptides.ACS Omega202541280784PubTator, text miningPubMed
A comprehensive review of new potential biomarkers in the detection of chronic kidney disease.Biomarkers202541246886PubTator, text miningPubMed
Associations of Plasma and Urine Uromodulin With Kidney Disease Progression in Persons With Chronic Kidney Disease and Hypertension: The Systolic Blood Pressure Intervention Trial.Kidney Med202541209167PubTator, text miningPubMed
The utility of urine biomarkers in diuretic resistance prediction in heart failure hospitalization.ESC Heart Fail202541163405PubTator, text miningPubMed
Unbiased self supervised learning of kidney histology reveals phenotypic and prognostic insights.Sci Rep202541062686PubTator, text miningPubMed
Integrated multi-optosis model for pan-cancer candidate biomarker and therapy target discovery.Front Bioinform202541048343PubTator, text miningPubMed
Amniotic fluid glycoproteins as potential ligands for macrophage galactose-type C-type lectin and their possible implications for immunoregulation during pregnancy.Sci Rep202541006428PubTator, text miningPubMed
Bio fluid exosomes: promises, challenges, and future directions in translational medicine.J Transl Med202540988065PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/7369/papers?page=6